Bajorin DF - Search Results

1

Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis.

Sirott MN, Bajorin DF, Wong GY, Tao Y, Chapman PB, Templeton MA, Houghton AN. Sirott MN, et al. Among authors: bajorin df. Cancer. 1993 Nov 15;72(10):3091-8. doi: 10.1002/1097-0142(19931115)72:10<3091::aid-cncr2820721034>3.0.co;2-v. Cancer. 1993. PMID: 8221576

2

Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanoma.

Bajorin DF, Chapman PB, Wong GY, Cody BV, Cordon-Cardo C, Dantes L, Templeton MA, Scheinberg D, Oettgen HF, Houghton AN. Bajorin DF, et al. Melanoma Res. 1992 Dec;2(5-6):355-62. doi: 10.1097/00008390-199212000-00009. Melanoma Res. 1992. PMID: 1292783

3

Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression.

Motzer RJ, Nanus DM, O'Moore P, Scher HI, Bajorin DF, Reuter V, Tong WP, Iversen J, Louison C, Albino AP, et al. Motzer RJ, et al. Among authors: bajorin df. Cancer Res. 1992 Oct 15;52(20):5775-9. Cancer Res. 1992. PMID: 1394202 Clinical Trial.

4

Immunotherapy with monoclonal antibodies in metastatic melanoma.

Steffens TA, Bajorin DF, Houghton AN. Steffens TA, et al. Among authors: bajorin df. World J Surg. 1992 Mar-Apr;16(2):261-9. doi: 10.1007/BF02071530. World J Surg. 1992. PMID: 1561808 Review.

5

Macrophage colony-stimulating factor: biological effects and potential applications for cancer therapy.

Bajorin DF, Cheung NK, Houghton AN. Bajorin DF, et al. Semin Hematol. 1991 Apr;28(2 Suppl 2):42-8. Semin Hematol. 1991. PMID: 1829550 Review. No abstract available.

6

Two-drug therapy in patients with metastatic germ cell tumors.

Bajorin DF, Geller NL, Weisen SF, Bosl GJ. Bajorin DF, et al. Cancer. 1991 Jan 1;67(1):28-32. doi: 10.1002/1097-0142(19910101)67:1<28::aid-cncr2820670106>3.0.co;2-3. Cancer. 1991. PMID: 1845937 Clinical Trial.

7

Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies.

Motzer RJ, Rodriguez E, Reuter VE, Samaniego F, Dmitrovsky E, Bajorin DF, Pfister DG, Parsa NZ, Chaganti RS, Bosl GJ. Motzer RJ, et al. Among authors: bajorin df. J Natl Cancer Inst. 1991 Mar 6;83(5):341-6. doi: 10.1093/jnci/83.5.341. J Natl Cancer Inst. 1991. PMID: 1847433

8

A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma.

Steffens TA, Bajorin DF, Chapman PB, Lovett DR, Cody-Johnson BV, Templeton MA, Heelan RT, Wong GY, Portlock CS, Oettgen HF, et al. Steffens TA, et al. Among authors: bajorin df. Cancer. 1991 Sep 15;68(6):1230-7. doi: 10.1002/1097-0142(19910915)68:6<1230::aid-cncr2820680608>3.0.co;2-q. Cancer. 1991. PMID: 1873774 Clinical Trial.

9

Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors.

Seidman AD, Scher HI, Heinemann MH, Bajorin DF, Sternberg CN, Dershaw DD, Silverberg M, Bosl GJ. Seidman AD, et al. Among authors: bajorin df. Cancer. 1991 Dec 15;68(12):2561-5. doi: 10.1002/1097-0142(19911215)68:12<2561::aid-cncr2820681205>3.0.co;2-g. Cancer. 1991. PMID: 1933802 Clinical Trial.

10

Phase II trial of cisplatin and etoposide in patients with metastatic melanoma.

Eton O, Bajorin DF, Chapman PB, Cody BV, Houghton AN. Eton O, et al. Among authors: bajorin df. Invest New Drugs. 1991 Feb;9(1):101-3. doi: 10.1007/BF00194558. Invest New Drugs. 1991. PMID: 2026478 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters